The McGill University Health Centre interdisciplinary approach to cancer pain management: Description of treatments and outcomes.

Authors

null

Sara Olivier

McGill University Health Centre, Montreal, QC, Canada

Sara Olivier, Jordi Perez, Yoram Shir, Manuel Borod, Rosemary O'Grady

Organizations

McGill University Health Centre, Montreal, QC, Canada, McGill Unviersity Health Centre, Montreal, QC, Canada

Research Funding

No funding sources reported

Background: Cancer-related symptom management is best achieved by interdisciplinary teams. In 2011, the MUHC launched an interdisciplinary Cancer Pain Clinic including palliative care, anesthesia, radiation oncology and nursing with rapid access to physiotherapy, occupational therapy and psychosocial oncology. Methods: We retrospectively analysed all new outpatients completing two subsequent visits since March 2013. Variables included a) symptom severity with the Edmonton Symptom Assessment Scale (ESAS), b) pain with the Brief Pain Inventory (BPI) and c) treatment including medication (type, formulation, dose of opioids) of non-pharmacological approaches. Results: 71 patients were analysed. Symptom management: Severity of pain and other five symptoms decreased significantly at V2 or V3 (Table). Pain significantly decreased in all four BPI categories. One third of patients had ≥50% pain relief at V2 or V3. Number of severe pain cases decreased (45% at V1 to 18% at V3) in parallel to an increase of mild pain cases (11% at V1, 41% at V3). Treatments: Acetaminophen, anticonvulsants and NSAIDs were the most common non-opioid drugs. Opioid prescription remained constant at an 80% yet the ratio between short acting (SA) and long acting (LA) changed at V3 compared to V1 (V1: SA/LA=76/44; V3: SA/LA=48/58) and the morphine equivalent daily doses decreased (V1: 100±194 mg, V2: 84±158mg and V3: 65±80mg). Among non-pharmacological methods, 28% of patients received interventional procedures, 18% psychotherapy and 12% palliative radiotherapy. Conclusions: We believe that the pain and other symptom improvement observed after three visits along with a lower opioid consumption is a result of the interdisciplinary approach offered.

ESAS ratings.
V1 V2 V3
Pain 6.9±2.2 5.3±2.7* 4.5±3.0+
Fatigue 6.3±2.7 5.6±2.6 5.2±3.0+
Nausea 2.3±3.1 1.7±2.5* 1.9±2.7
Depression 3.0±3.2 2.0±2.7* 2.2±2.8
Anxiety 4.1±3.2 2.6±2.6* 2.8±3.1+
Drowsiness 4.7±2.9 3.2±2.7* 3.3±3.3+
Appetite 5.0±3.0 4.3±2.9 4.2±2.8
Well being 5.4±2.8 4.6±2.7 4.4±2.7+
Shortness of breath 3.3±3.2 3.0±3.1 3.1±3.2

Data show ave.± st dev.; * V1 vs. V2 comparison p<0.05; + V1 vs. V3 comparison p<0.05.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2014 Palliative and Supportive Care in Oncology Symposium

Session Type

Poster Session

Session Title

General Poster Session A: End-of-Life Care, <span>Patient-Reported Outcomes</span>, and Survivorship

Track

Survivorship,Patient-Reported Outcomes: Mechanisms of Symptoms and Treatment Toxicities,Early Integration of Palliative Care in Cancer Care,Psycho-oncology,End-of-Life Care

Sub Track

Patient-Reported Outcomes: Mechanisms of Symptoms and Treatment Toxicities

Citation

J Clin Oncol 32, 2014 (suppl 31; abstr 190)

DOI

10.1200/jco.2014.32.31_suppl.190

Abstract #

190

Poster Bd #

F8

Abstract Disclosures

Similar Abstracts

First Author: Desiree Rachel Azizoddin

First Author: Christopher John Coyne

Abstract

2023 ASCO Annual Meeting

Quality of pain management in patients with cancer in the outpatient setting.

First Author: Biplov Adhikari

Abstract

2022 ASCO Quality Care Symposium

Smartphone pain app for assessment of radiation-induced oral mucositis pain.

First Author: Aditya V. Shreenivas